{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:00:42Z","timestamp":1785387642463,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,29]]},"DOI":"10.7759\/cureus.113624","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:44:28Z","timestamp":1785386668000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Thyroid Dermopathy"],"prefix":"10.7759","author":[{"given":"Andrew J","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Peter","family":"Sarantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith TJ","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves' disease. N Engl J Med. 2016, 375:1552-65. 10.1056\/NEJMra1510030","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies TF","year":"2020","unstructured":"Davies TF, Andersen S, Latif R, et al.. Graves' disease. Nat Rev Dis Primers. 2020, 6:52. 10.1038\/s41572-020-0184-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0097-2","article-title":"Extrathyroidal manifestations of Graves' disease: a 2014 update","volume":"37","author":"Bartalena L","year":"2014","unstructured":"Bartalena L, Fatourechi V. Extrathyroidal manifestations of Graves' disease: a 2014 update. J Endocrinol Invest. 2014, 37:691-700. 10.1007\/s40618-014-0097-2","journal-title":"J Endocrinol Invest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200506050-00003","article-title":"Pretibial myxedema: pathophysiology and treatment options","volume":"6","author":"Fatourechi V","year":"2005","unstructured":"Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005, 6:295-309. 10.2165\/00128071-200506050-00003","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.001","article-title":"Thyroid dermopathy and acropachy","volume":"26","author":"Fatourechi V","year":"2012","unstructured":"Fatourechi V. Thyroid dermopathy and acropachy. Best Pract Res Clin Endocrinol Metab. 2012, 26:553-65. 10.1016\/j.beem.2011.10.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/10507250050137761","article-title":"Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease","volume":"10","author":"Rapoport B","year":"2000","unstructured":"Rapoport B, Alsabeh R, Aftergood D, McLachlan SM. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid. 2000, 10:685-92. 10.1089\/10507250050137761","journal-title":"Thyroid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/10507250360731541","article-title":"Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy","volume":"13","author":"Fatourechi V","year":"2003","unstructured":"Fatourechi V, Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DD, Garrity JA. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy. Thyroid. 2003, 13:1141-4. 10.1089\/10507250360731541","journal-title":"Thyroid"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8220","article-title":"Dermopathy of Graves' disease (pretibial myxedema): long-term outcome","volume":"87","author":"Schwartz KM","year":"2002","unstructured":"Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab. 2002, 87:438-46. 10.1210\/jcem.87.2.8220","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21700","article-title":"Teprotumumab as a novel treatment for pretibial myxoedema","volume":"187","author":"Mervis JS","year":"2022","unstructured":"Mervis JS, Maeng MM, Kirsner RS, Wester ST. Teprotumumab as a novel treatment for pretibial myxoedema. Br J Dermatol. 2022, 187:795-7. 10.1111\/bjd.21700","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6854","article-title":"Improvement of pretibial myxedema following administration of teprotumumab","volume":"21","author":"Washington A","year":"2022","unstructured":"Washington A, Nam H, Pitch M, Anderson B, Stokes J, Helm M. Improvement of pretibial myxedema following administration of teprotumumab. J Drugs Dermatol. 2022, 21:1252-4. 10.36849\/JDD.6854","journal-title":"J Drugs Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/512312-a-case-of-thyroid-dermopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:44:31Z","timestamp":1785386671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/512312-a-case-of-thyroid-dermopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.113624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}